2026-06-01T16:46:40Zhttps://riuma.uma.es/rest/oai/requestoai:riuma.uma.es:10630/399192026-02-03T10:51:43Zcom_10630_2254col_10630_37953
De-Vivero-de-Porras, María del Carmen
Sanjuán-Muñoz, Enrique
2025-09-16T06:24:32Z
2025-09-16T06:24:32Z
2025-07-28
de Vivero de Porras C, Sanjuán y Muñoz E. Abuse of Dominant Position, Effective Judicial Protection and Abuse of Procedure. Journal of Law, Medicine & Ethics. 2025;53(3):379-387. doi:10.1017/jme.2025.10145
https://hdl.handle.net/10630/39919
10.1017/jme.2025.10145
On October 21, 2022, the Spanish Competition Agency (CNMC) sanctioned the North American pharmaceutical company Merck Sharp & Dohme for abuse of a dominant position. The practice for which it was finally sanctioned consisted of the adoption of a strategy aimed at delaying and making it difficult for another company to enter the Spanish medicines market in order to protect sales for a product marketed exclusively by that company and for which had a patent. This paper analyzes this resolution in an attempt to delimit the difference between the legitimate exercise of the right to effective judicial protection and its abuse.
eng
http://creativecommons.org/licenses/by/4.0/
open access
Atribución 4.0 Internacional
Competencia económica desleal
Industria farmacéutica
Medicamentos -- Legislación
Medicamentos -- Derecho
Derecho mercantil
Comercio -- Regulación
Patentes -- Derecho
Abuse of Dominant Position, Effective Judicial Protection and Abuse of Procedure
journal article